|
|
Valeant Pharmaceuticals International - Price Analysis Snapshot
This Report features up to a ten-year record of the equity Price history for Valeant Pharmaceuticals International. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.
Valeant Pharmaceuticals International. The Group's principal activity is to develop, manufacture and market prescription and non-prescription pharmaceutical products principally in the areas of neurology and dermatology. The Company's growth strategy is to acquire, develop and commercialize new products through strategic partnerships, and build on the company's market in neurology and dermatology. The Group's markets focus primarily in the United States, Canada, Mexico, Brazil and Australia. Headquartered in Orange County, California, Valeant has approximately 2,600 employees worldwide.
Not the Report you are looking for? Click here for more browsing options.
Layout and Content of a Typical Report
|
|
|
|
|